Viewing Study NCT07231250


Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2026-01-02 @ 10:27 AM
Study NCT ID: NCT07231250
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2025-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Sponsor: Li Zhiming
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module